Table 2 shows that the number of duodenal epithelial lymphocytes in the old model group is significantly lower than that in the young control group (P<0.05). Compared with the aged control group, the number of duodenal epithelial lymphocytes in each dose group increased significantly (P<0.05). Compared with the young control group, the number of jejunal epithelial lymphocyte in the old model group was significantly decreased (P<0.05) and the number of jejunal epithelial lymphocyte in each dose group was significantly increased compared with the aged control group (P<0.05). Table 2 shows that the number of epithelial lymphocytes in the ileum of the old model group is lower than that of the young control group, but the difference is non-significant. Compared with the aged control group, the difference between the high dose group and the old model group was statistically significant (P<0.05).
Table 3 shows that the duodenal mucosal thickness of the aging model group is significantly. (P<0.05) higher than that of the young control group.
Table 3 shows that the thickness of ileal mucosa in the aging model group was significantly lower than that in the young control group (P<0.05). The thickness of ileal mucosa was increased in each dose group and there was a significant difference between the middle dose group and the model group (P<0.05).
As a special component of intestinal related lymphoid tissue, intestinal mucosal intraepithelial lymphocyte is the first immune cell contacted by immune system, foreign antigens and microorganisms. Therefore, the number of intraepithelial lymphocytes in small intestinal mucosa can reflect the integrity of the local mucosal immune barrier and the perfection of the immune defense function of small intestine
(Hong et al., 2006). The results showed that the number of epithelial lymphocyte in duodenum, jejunum and ileum of aging model group was less than that of young mice, which indicated that with aging, the ability of intestinal defense against pathogenic microorganism invasion decreased and the mucosal immune function of small intestine also decreased, which was consistent with the results of Ren W Y
(Ren et al., 2014). From the results of this study, we can see that each dose of β-CM-7 can increase the number of lymphocyte in each intestinal segment of aging mice and thus play a protective role in the intestinal immune function of aging organisms. In addition, some studies have shown that β-CM-7 can promote the immune function of the digestive tract of weaned piglets
(Wang et al., 2016).
During aging, the intestinal mucosa shrinks, its thickness decreases and bacteria contact with epithelium directly too much, which makes the intestinal mucosa as a physical barrier of epithelium ineffective and the barrier function deteriorates gradually, resulting in a series of changes in immune response in the elderly. The results showed that the thickness of duodenum and jejunum mucosa in the aged model mice was increased compared with that in the young mice and the thickness of ileum mucosa was decreased. It was reported that the ileum was more prone to structural damage in the age-related histological changes of the small intestine
(Omotoso et al., 2012). After feeding β-CM-7, the mucosal thickness of the whole small intestine segment was increased at medium dose. In conclusion, β-CM-7 has a certain beneficial effect on the intestinal mucosal thickness of senile organisms.
TLR is an important innate immune recognition receptor. TLR2 and TLR4 participate in intestinal mucosal immune response. The mechanism of TLR signal transduction pathway in intestinal mucosa is to defend pathogens. Studies have shown that TLR can be involved in the protection of Salmonella infection, which indicates that TLR4 can interact with other TLRs to prevent intestinal infections of pathogenic bacteria
(Alvesalo et al., 1977). In this study, we found that the relative expression of TLR4 in intestinal mucosa of aged mice was lower than that of young mice, while β-CM-7 could effectively increase the expression of TLR4 in intestinal mucosa of mice (in Fig 1), promote the high expression of TLRs-related signals MyD88 and TRIF, activate NF-κB and regulate the immune function of intestinal mucosa of mice through MyD88 dependent/independent dual pathways. Recent studies have found that MyD88-dependent pathway mediated by TLRs is the main signal pathway for activating NF-κB in cells
(Miao et al., 2011 and
Wang et al., 2017 and
Takaesu et al., 2003). When pathogens invade, TLRs act on the cell membrane and activate it. TLRs transduction pathways include MyD88 dependent pathway and MyD88 independent pathway (or TRIF pathway). TLR4 is mediated by both MyD88 and TRIF pathways.
NF-κB signaling pathway is an important way to link the body’s antioxidant system with the immune system. NF-κB is a transcription factor sensitive to oxidative stress, which is involved in inflammation, congenital immunity, cell differentiation and apoptosis
(Cummins et al., 2010 and
Garg et al., 2012). In addition, NF-κB is located in the downstream signaling pathway of TLRs, which can facilitate gene transcription and expression by combining the specific locations of multiple gene promoters and enhancers. The results showed that the relative expression of NF-κB gene in intestinal mucosa of aged mice was lower than that of young mice. After the intervention of β-CM-7, the relative expression of NF-κB gene in intestinal mucosa of aged mice could be up-regulated in each dose group (Fig 2), which indicated that β-CM-7 could activate the transcription of NF-κB and promote the release of NF-κB protein. According to the results of this study, it can be inferred that the mechanism of β-CM-7 improving intestinal mucosal immunity may be through activating the transcription of NF-κB, promoting the release of NF-κB, further activating the specific immune system, inducing the proliferation of lymphocytes and the expression of SIgA and cytokines, so as to alleviate the intestinal mucosal immunity caused by aging.
Studies have shown that the regulation of NF-κB mainly involves TRAF6 and that NF-κB and TRAF6 are the major signal transduction genes downstream of TLR4
(Verstak et al., 2009 and
Ma et al., 2018). TLRs signal triggers MyD88/TRAF6-dependent signaling pathway by dimeric Toll receptor mediated by extracellular domain, activates NF-κB protein in cytoplasm and participates in the regulation of large-scale inflammatory response. TRAF6 pathway produces cytokines and adhesion molecules to regulate acquired immunity and enhance cellular immunity. It is the necessary pathway for downward transduction of TLRs signal such as TLR1, TLR2, TLR4, TLR5, TLR7 and TLR9. The results showed that the relative expression of TRAF6 gene in intestinal mucosa of aged mice was lower than that of young mice. After the intervention of β-CM-7, the relative expression of TRAF6 gene in intestinal mucosa of aged mice could be up-regulated in each dose group (Fig 3). It indicated that β-CM-7 could activate TRAF6 and regulate the activation of NF-κB, thus regulating the intestinal immune function.
In conclusion, aging can lead to the decrease of relative expression of TLR4, TRAF6 and NF-κB genes in intestinal mucosa, while β-CM-7 can significantly. (P<0.05) increase the expression of TLR4 and activate NF-κB in intestinal mucosa of mice. Then, the relative expression of TRAF6 gene in intestinal mucosa of aged mice was up-regulated to regulate the activation of NF-κB, so as to regulate the intestinal and overall immune function. It is suggested that the protective mechanism of β-CM-7 on intestinal mucosa of aged animals is related to the expression of TLR4, TRAF6 and NF-κB genes.